Tokio Marine Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-2,463
Closed -$455K – 568
2024
Q4
$455K Buy
2,463
+485
+25% +$93.4K 0.02% 501
2024
Q3
$390K Buy
1,978
+24
+1% +$4.99K 0.02% 516
2024
Q2
$404K Sell
1,954
-32
-2% -$7.25K 0.02% 478
2024
Q1
$538K Buy
1,986
+383
+24% +$91.5K 0.03% 415
2023
Q4
$379K Buy
1,603
+133
+9% +$26.2K 0.02% 480
2023
Q3
$288K Buy
1,470
+128
+10% +$26.3K 0.02% 506
2023
Q2
$282K Buy
1,342
+38
+3% +$7.56K 0.02% 494
2023
Q1
$263K Buy
1,304
+119
+10% +$27K 0.02% 496
2022
Q4
$258K Buy
1,185
+135
+13% +$29.5K 0.02% 474
2022
Q3
$207K Buy
1,050
+58
+6% +$12.5K 0.02% 481
2022
Q2
$212K Buy
992
+239
+32% +$58.4K 0.02% 474
2022
Q1
$214K Buy
753
+68
+10% +$21K 0.02% 477
2021
Q4
$258K Buy
685
+78
+13% +$30.3K 0.02% 426
2021
Q3
$250K Buy
+607
New +$252K 0.02% 394

Other funds holding CRL

Tokio Marine Asset Management's CRL Position: Q1 2025 in Review

Tokio Marine Asset Management sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 2,463 shares — an estimated $455K sold.

Tokio Marine Asset Management first reported a position in CRL in Q3 2021 and held it in 14 quarters. The position peaked at $538K in Q1 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Tokio Marine Asset Management reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Tokio Marine Asset Management sold 2,463 Charles River Laboratories shares in Q1 2025, an estimated $455K.
  • Tokio Marine Asset Management first reported a position in Charles River Laboratories in Q3 2021 and held it in 14 quarters.
  • Tokio Marine Asset Management's Charles River Laboratories position peaked at $538K in Q1 2024.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Tokio Marine Asset Management's 13F filing for Q1 2025, filed 13 May 2025.